Home HEALTH Zydus Lifesciences gets USFDA nod for asthma treatment drug

Zydus Lifesciences gets USFDA nod for asthma treatment drug

38
0


Zydus Lifesciences Ltd receives final USFDA approval to market generic Theophylline extended-release tablets of strengths 300 mg and 450 mg for asthma and COPD treatment. The drug will be manufactured at the group’s formulation manufacturing facility in Ahmedabad SEZ, India, with annual sales of USD 12.6 million citing IQVIA MAT March 2024 data.